IV. To explore the possibility of identifying tumor genetic mutations in (1) cell-free (cf) circulating tumor DNA (ctDNA), (2) deoxyribonucleic acid/ribonucleic acid (DNA/RNA) isolated from exosomes, and determine the concordance of these results and that from NGS.